Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-PD-1 antibodies for treatment of lung cancer

Anti-PD-1 antibodies for treatment of lung cancer

US Patent 11292842 · Granted Apr 5, 2022

Estimated economic value: $173,088,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Intralesional administration of PD-1 inhibitors for treating skin cancer2025
Combination therapy to treat brain cancer2025
Combination of anti-PD-1 antibodies and bispecific anti-CD20/anti-CD3 antibodies2024
Anti-PD-1 antibodies for treatment of lung cancer2024
Anti-PD-1 antibodies for treatment of lung cancer2024
Methods of treating multiple myeloma with bispecific anti-BCMA x anti-CD3 antibo2024
Dosing strategy that mitigates cytokine release syndrome for therapeutic antibod2023
Methods of treating skin cancer by administering a PD-1 inhibitor2022
Anti-angiogenic therapy of metastatic colorectal cancer2022
Methods for tumor treatment using CD3XCD20 bispecific antibody2020
B cell lineage based immunogen design with humanized animals2020
Methods and compositions comprising a combination of a VEGF antagonist and an an2020